VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-8.99%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$399M
AUM Growth
+$399M
(+0.76%)
Cap. Flow
+$85M
Cap. Flow
% of AUM
21.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$87.3M |
Top Sells
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$2.06M |
| 2 |
Assembly Biosciences
ASMB
|
$254K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $87.3M | 21.9% |
+3,931,818
| New | +$87.3M |
|
|
KRON
2
DELISTED
Kronos Bio
KRON
| $66.2M | 16.61% |
2,765,314
| – | – |
|
|
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $64M | 16.04% |
2,747,433
| – | – |
|
4
Dyne Therapeutics
DYN
$1.92B
| $62.3M | 15.62% |
2,960,046
| – | – |
|
5
Praxis Precision Medicines
PRAX
$958M
| $53.7M | 13.47% |
2,939,329
| – | – |
|
6
Allogene Therapeutics
ALLO
$251M
| $46.9M | 11.76% |
1,798,163
| – | – |
|
|
OYST
7
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $11.3M | 2.84% |
658,468
-120,000
| -15% | -$2.06M |
|
8
Q32 Bio
QTTB
$20.9M
| $5.6M | 1.41% |
770,845
| – | – |
|
|
9
Assembly Biosciences
ASMB
$190M
| $1.49M | 0.37% |
384,635
-65,365
| -15% | -$254K |
|